Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ORAGENICS INC Director's Dealing 2015

Mar 18, 2015

35380_dirs_2015-03-18_e23f9e9c-ad01-4724-b20b-7ab37d57e94e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAGENICS INC (OGEN)
CIK: 0001174940
Period of Report: 2015-03-16

Reporting Person: Telling Fred (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-03-16 Common Stock A 40000 $0.00 Acquired 306174 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-03-16 Non-Employee Director Option (Right to Buy) $1.32 A 80000 Acquired 2025-03-16 Common Stock (80000) Direct

Footnotes

F1: Represents an award of restricted stock in connection with service to the Company pursuant to the 2012 Equity Incentive Plan that vests equally over each of the four calendar quarters during 2015.

F2: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, that vest equally over three years commencing on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, March 16, 2015.